Presented by
Dr. Jochen Welcker, PhD
CRISPR/Cas gene editing burst into the in vivo genetic engineering scene almost two year ago. Numerous models have been created and characterized.
How is this technology holding up against all the hype? This webinar will address some of the experiences from Taconic’s implementation of CRISPR/Cas-technology to routine model generation.
Key Learning Points:
- Our experiences from the implementation of CRISPR/Cas technology to routine model generation
- A comparison between CRISPR/Cas performance against established homologous-recombination methodology in ES-cells
- Tailoring and refining existing humanized mouse models to speed up model refinement
- The generation of knock-in and conditional knock-out alleles
